Publications

Detailed Information

The interleukin-8-251 AA genotype is associated with angiogenesis in gastric carcinogenesis in Helicobacter pylori-infected Koreans

DC Field Value Language
dc.contributor.authorSong, Ji Hyun-
dc.contributor.authorKim, Sang Gyun-
dc.contributor.authorJung, Sung-Ae-
dc.contributor.authorLee, Mi Kyoung-
dc.contributor.authorSong, In Sung-
dc.contributor.authorJung, Hyun Chae-
dc.date.accessioned2012-05-25T05:02:46Z-
dc.date.available2012-05-25T05:02:46Z-
dc.date.issued2010-08-
dc.identifier.citationCYTOKINE; Vol.51 2; 158-165ko_KR
dc.identifier.issn1043-4666-
dc.identifier.urihttps://hdl.handle.net/10371/76463-
dc.description.abstractHelicobacter pylori (H. pylori) is an important risk factor of gastric adenocarcinoma. Interleukin (IL)-8 is a potent angiogenic factor and plays an important role in inflammation of gastric mucosa by H. pylori. Host susceptibility may help to predict H. pylori-infected individuals with a higher risk of gastric adenocarcinoma. The aim of this study was to clarify the effect of IL-8 polymorphism on angiogenesis in the process of gastric carcinogenesis in H. pylori-infected Koreans. The IL-8-251A/T polymorphism was genotyped by PCR-RFLP from a total of 395 subjects; 92 normal controls, 87 H. pylori-infected controls, 108 chronic atrophic gastritis and/or intestinal metaplasia and 108 adenocarcinoma. The gastric mucosal concentrations of IL-8, membrane metalloproteinase (MMP)-9, angiopoietin (Ang)-1, and vascular endothelial growth factor (VEGF) were measured by ELISA. MMP-9 concentrations were increased with disease progression. There was significant correlation between MMP-9 and disease progression in AA (r = 0.42, p < 0.01) and AT genotype (r = 0.43, p < 0.01). Ang-1 concentrations were increased in AA genotype (r = 0.40, p = 0.01). However, there was no significant correlation between VEGF and disease progression in AA genotype. In conclusion, IL-8-251 AA genotype may be associated with angiogenesis in gastric carcinogenesis in H. pylori-infected Koreans. (C) 2010 Elsevier Ltd. All rights reserved.ko_KR
dc.language.isoenko_KR
dc.publisherACADEMIC PRESS LTD- ELSEVIER SCIENCE LTDko_KR
dc.subjectHelicobacter pyloriko_KR
dc.subjectAngiogenesisko_KR
dc.subjectPolymorphismko_KR
dc.subjectGastric cancerko_KR
dc.subjectInterleukin-8ko_KR
dc.titleThe interleukin-8-251 AA genotype is associated with angiogenesis in gastric carcinogenesis in Helicobacter pylori-infected Koreansko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor송지현-
dc.contributor.AlternativeAuthor김상균-
dc.contributor.AlternativeAuthor정성애-
dc.contributor.AlternativeAuthor이미경-
dc.contributor.AlternativeAuthor정현채-
dc.contributor.AlternativeAuthor송인성-
dc.identifier.doi10.1016/j.cyto.2010.05.001-
dc.citation.journaltitleCYTOKINE-
dc.description.citedreferenceYe BD, 2009, J CLIN GASTROENTEROL, V43, P233, DOI 10.1097/MCG.0b013e3181646701-
dc.description.citedreferenceVarey AHR, 2008, BRIT J CANCER, V98, P1366, DOI 10.1038/sj.bjc.6604308-
dc.description.citedreferenceCanedo P, 2008, EUR J CANCER PREV, V17, P28-
dc.description.citedreferenceWu MS, 2007, J INFECT DIS, V196, P1386, DOI 10.1086/522520-
dc.description.citedreferenceDing SZ, 2007, INFECT IMMUN, V75, P4030, DOI 10.1128/IAI.00172-07-
dc.description.citedreferenceGao ZL, 2007, HEPATO-GASTROENTEROL, V54, P1591-
dc.description.citedreferenceKundu P, 2006, J BIOL CHEM, V281, P34651, DOI 10.1074/jbc.M604574200-
dc.description.citedreferenceZheng HC, 2006, ANTICANCER RES, V26, P3579-
dc.description.citedreferencePousa ID, 2006, REV ESP ENFERM DIG, V98, P527-
dc.description.citedreferenceWang J, 2006, WORLD J GASTROENTERO, V12, P2450-
dc.description.citedreferenceSavage SA, 2006, CANCER EPIDEM BIOMAR, V15, P589, DOI 10.1158/1055-9965.EPI-05-0887-
dc.description.citedreferenceYeo M, 2006, GUT, V55, P26, DOI 10.1136/gut.2005.067454-
dc.description.citedreferenceSun WH, 2005, JPN J CLIN ONCOL, V35, P707, DOI 10.1093/jjco/hyi196-
dc.description.citedreferenceTaguchi A, 2005, CANCER EPIDEM BIOMAR, V14, P2487, DOI 10.1158/1055-9965.EPI-05-0326-
dc.description.citedreferenceLee WP, 2005, CLIN CANCER RES, V11, P6431, DOI 10.1158/1078-0432.CCR-05-0942-
dc.description.citedreferenceArinir U, 2005, ELECTROPHORESIS, V26, P2888, DOI 10.1002/elps.200500095-
dc.description.citedreferenceOhyauchi M, 2005, GUT, V54, P330, DOI 10.1136/gut.2003.033050-
dc.description.citedreferenceLu WL, 2005, CARCINOGENESIS, V26, P631, DOI 10.1093/carcin/bgh349-
dc.description.citedreferenceGologan A, 2005, CLIN LAB MED, V25, P197, DOI 10.1016/j.cll.2004.12.002-
dc.description.citedreferenceXUAN J, 2005, TOKAI J EXP CLIN MED, V30, P83-
dc.description.citedreferenceBaek HY, 2004, BIOCHEM J, V379, P291-
dc.description.citedreferenceSTROWSKI MZ, 2004, FASEB J, V18, P218-
dc.description.citedreferenceKitadai Y, 2003, BIOCHEM BIOPH RES CO, V311, P809, DOI 10.1016/j.bbrc.2003.10.077-
dc.description.citedreferenceTutton MG, 2003, INT J CANCER, V107, P541, DOI 10.1002/ijc.11436-
dc.description.citedreferenceCrawford HC, 2003, GASTROENTEROLOGY, V125, P1125, DOI 10.1053/S0016-5085(03)01206-X-
dc.description.citedreferenceTsigkos S, 2003, EXPERT OPIN INV DRUG, V12, P933-
dc.description.citedreferenceSasaki A, 2003, SCAND J GASTROENTERO, V38, P153-
dc.description.citedreferenceInnocenti M, 2002, INFECT IMMUN, V70, P4581, DOI 10.1128/IAI.70.8.4581-4590.2002-
dc.description.citedreferenceMaeda S, 2002, GUT, V50, P771-
dc.description.citedreferenceGupta RA, 2001, J BIOL CHEM, V276, P31059-
dc.description.citedreferenceEck M, 2000, CLIN EXP IMMUNOL, V122, P192-
dc.description.citedreferenceEl-Omar EM, 2000, NATURE, V404, P398-
dc.description.citedreferenceKim JS, 2000, DIGEST DIS SCI, V45, P83-
dc.description.citedreferenceKitadai Y, 1999, BRIT J CANCER, V81, P647-
dc.description.citedreferenceKim JS, 1998, SCAND J GASTROENTERO, V33, P1249-
dc.description.citedreferenceLindholm C, 1998, INFECT IMMUN, V66, P5964-
dc.description.citedreferenceFox SH, 1998, J SURG ONCOL, V69, P230-
dc.description.citedreferenceKitadai Y, 1998, AM J PATHOL, V152, P93-
dc.description.citedreferenceErnst PB, 1997, GASTROENTEROLOGY, V113, pS35-
dc.description.citedreferenceKuipers EJ, 1997, ALIMENT PHARM THERAP, V11, P71-
dc.description.citedreferenceDixon MF, 1996, AM J SURG PATHOL, V20, P1161-
dc.description.citedreferenceBagchi D, 1996, FREE RADICAL RES, V24, P439-
dc.description.citedreferenceCORREA P, 1992, CANCER RES, V52, P6735-
dc.description.citedreferenceMAI UEH, 1991, J CLIN INVEST, V87, P894-
dc.description.citedreferenceFOLKMAN J, 1990, J NATL CANCER I, V82, P4-
dc.description.citedreferencePETERSON GL, 1977, ANAL BIOCHEM, V83, P346-
dc.description.tc2-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share